XNAS · NDRA
+7.58% · +$0.3200 · Vol 20.2K
Market closed · last close 4:00 PM ET · price as of 15:56:38 ET
ENDRA Life Sciences Inc. Common Stock

ENDRA Life Sciences Inc. Common Stock

ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
$4.54
Card
Relationship Map

Veridion Score

BETAMEDIUM CONF · 5/6 factorsMethodology
NDRA
ENDRA Life Sciences Inc. Common Stock
Wed Aug 5 · session closed · Markets closed · resumes Thu 9:30 ET
SELL BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

41/ 100
Veridion Score
SELL BIAS · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5/6 factors with data · Wed Aug 5 · session closed · Markets closed · resumes Thu 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is NDRA moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading NDRA catalysts
About ENDRA Life Sciences Inc. Common Stock
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Listed since
2017
Employees
11
Country
US

ENDRA Life Sciences Inc is engaged in the development of thermo-acoustic enhanced ultrasound (TAEUS) technology to improve the capabilities of clinical diagnostic ultrasound. The company's technology is used to measure tissue composition, including the assessment of fat in the liver, and is being developed for additional clinical applications such as tissue temperature monitoring.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$4.20
Day high
$4.68
Day low
$4.20
Previous close
$4.22
52W high
$8.12
-44.09% from high
52W low
$3.26
26% of range
Market cap
$5.4M
EPS
$-6.3800
Beta
1.51
Shares out
1.3M
Volume
20.2K
0.43× rel vol
Avg volume
47.4K
VWAP
$4.51
Price history computed in-house
1W
+2.02%
1M
-5.22%
3M
-8.28%
1Y
-11.50%
YTD
+0.22%
SMA 50 $4.95 · below
SMA 200 $4.83 · below
52W position 26%

NDRA overview

Veridion Score
41
5 of 6 factors measured
Congress receipts
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around NDRA.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading NDRA Form 4 filings
Public disclosures

Congress activity in NDRA

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for NDRA in the cached public ledger.

Federal contracts

NDRA contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for NDRA in this window.
Lobbying spend

NDRA lobbying filings, year to date.

Registered lobbying filings matched to ENDRA Life Sciences Inc. Common Stock.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for NDRA in this window.
Loading news for NDRA
Analyst ratings
Sovereign unlock shows live analyst consensus for NDRA.
Options
Sovereign unlock shows live options positioning for NDRA.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.